First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Sancy A LeachmanRoger L Kaspar

Abstract

The rare skin disorder pachyonychia congenita (PC) is an autosomal dominant syndrome that includes a disabling plantar keratoderma for which no satisfactory treatment is currently available. We have completed a phase Ib clinical trial for treatment of PC utilizing the first short-interfering RNA (siRNA)-based therapeutic for skin. This siRNA, called TD101, specifically and potently targets the keratin 6a (K6a) N171K mutant mRNA without affecting wild-type K6a mRNA. The safety and efficacy of TD101 was tested in a single-patient 17-week, prospective, double-blind, split-body, vehicle-controlled, dose-escalation trial. Randomly assigned solutions of TD101 or vehicle control were injected in symmetric plantar calluses on opposite feet. No adverse events occurred during the trial or in the 3-month washout period. Subjective patient assessment and physician clinical efficacy measures revealed regression of callus on the siRNA-treated, but not on the vehicle-treated foot. This trial represents the first time that siRNA has been used in a clinical setting to target a mutant gene or a genetic disorder, and the first use of siRNA in human skin. The callus regression seen on the patient's siRNA-treated foot appears sufficiently promising...Continue Reading

References

Dec 17, 2004·Molecular and Cellular Biology·Pauline WongPierre A Coulombe
Oct 28, 2005·The Journal of Investigative Dermatology. Symposium Proceedings·Sancy A LeachmanE Birgitte Lane
Oct 28, 2005·The Journal of Investigative Dermatology. Symposium Proceedings·Frances J D SmithW H Irwin McLean
Oct 28, 2005·The Journal of Investigative Dermatology. Symposium Proceedings·Roger L Kaspar
Oct 5, 2007·The Journal of Investigative Dermatology·Robyn P HickersonRoger L Kaspar
Mar 28, 2008·Nature·Mark E KleinmanJayakrishna Ambati
Apr 26, 2008·Human Gene Therapy·Dirk Haussecker
May 23, 2008·Journal of Dermatological Science·Sancy A LeachmanRoger L Kaspar
Oct 11, 2008·Oligonucleotides·Robyn P HickersonRoger L Kaspar
Jan 23, 2009·Nature·Daniela Castanotto, John J Rossi
Jan 31, 2009·Nature Reviews. Drug Discovery·Kathryn A WhiteheadDaniel G Anderson

❮ Previous
Next ❯

Citations

Sep 18, 2012·Archives of Dermatological Research·Tina ZupancicMirjana Liovic
Jun 24, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Emilio Gonzalez-GonzalezRoger L Kaspar
Dec 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xiang YiJames Q Yin
Apr 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yang Liu, Leaf Huang
Dec 22, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Garrett R Rettig, Mark A Behlke
Oct 24, 2013·Molecular Therapy. Nucleic Acids·Robyn P HickersonRoger L Kaspar
Sep 8, 2010·The New England Journal of Medicine·Leena Bruckner-Tuderman
Jul 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Dan ZhengAmy S Paller
Aug 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Erika I GeihePaul A Wender
Sep 21, 2012·Human Gene Therapy·Francesca GualandiAlessandra Ferlini
Nov 1, 2011·Human Molecular Genetics·Julien ColasAleksander Edelman
Dec 13, 2012·Investigative Ophthalmology & Visual Science·Edwin H A AllenC B Tara Moore
Jul 3, 2010·Journal of Biomedical Science·Rasmus O Bak, Jacob G Mikkelsen
Jul 10, 2010·Silence·Akshay K VaishnawJohn Maraganore
Aug 24, 2012·International Journal of Nanomedicine·Evelina MieleAlberto Gulino
Oct 15, 2013·Therapeutic Delivery·Yuwei Wang, David W Grainger
Nov 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Juliane C LessardPierre A Coulombe
Jul 27, 2012·Therapeutic Delivery·Manfred Ogris, David Schaffert
Jan 25, 2013·Pharmaceutical Research·Fabiana Testa Moura de Carvalho VicentiniMaria Vitória Lopes Badra Bentley
Jun 6, 2014·Annual Review of Genomics and Human Genetics·Cristina Has, Leena Bruckner-Tuderman
Mar 16, 2013·Human Genetics·Tamara MartínezCovadonga Pañeda
Feb 27, 2015·Expert Review of Clinical Immunology·Marianne B Løvendorf, Lone Skov
May 29, 2015·Expert Opinion on Biological Therapy·Marina A Dobrovolskaia, Scott E McNeil
Nov 26, 2015·Expert Opinion on Drug Delivery·Ibrahim A AljuffaliJia-You Fang
Feb 19, 2016·Scientific Reports·Yan DengTao Tang
Feb 24, 2015·Critical Reviews in Biotechnology·Yi Liao, Liling Tang
Nov 17, 2012·The Journal of Investigative Dermatology·Jouni Uitto
Aug 26, 2010·Journal of Pharmaceutical Sciences·Gunilla B JacobsonRichard N Zare
Sep 7, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Oscar HaighMark A F Kendall
Feb 11, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cornelia LorenzerJohannes Winkler
Jul 15, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Robyn P HickersonRoger L Kaspar
Jan 3, 2012·Biomaterials·Hamidreza M AliabadiHasan Uludağ
Jan 24, 2012·Journal of the American Academy of Dermatology·Mark J EliasonC David Hansen
Feb 11, 2015·Advanced Drug Delivery Reviews·Gulnihal OzcanGabriel Lopez-Berestein
Jan 8, 2016·Annual Review of Pharmacology and Toxicology·Maggie L Bobbin, John J Rossi
Nov 13, 2013·The Journal of Investigative Dermatology·Vinod E Nambudiri, Hans R Widlund
Mar 2, 2011·Advanced Drug Delivery Reviews·Jenny Ka-Wing LamHak-Kim Chan
Oct 12, 2010·Annales de dermatologie et de vénéréologie·O Dereure

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Investigative Dermatology
Robyn P HickersonRoger L Kaspar
The Journal of Investigative Dermatology
Robyn P HickersonRoger L Kaspar
© 2022 Meta ULC. All rights reserved